Email your diabetes stories to editor Oliver Jelley.

Join the expanding diabetes community on Twitter and follow us for the latest diabetes news updates at @DiabetesTimes.

"If you are anonymous, you don't exist to me…"

That line stuck in my head a fair bit after my meet with Helen - the RCGP Chair. Among many topics, we had touched upon social media, bullying and I liked her style of dealing with it. I have seen some of the vitriol she and Jane Dacre, not to mention Bruce Keogh, have sometimes copped. They have rode that wave admirably. I have been comparatively lucky, though a few messages from evangelists within the low carb lobby have stuck in my mind.

"What does a p*** know about low carbs? Go and feed your kids those sh***".

Ah yes…lovely indeed. Apart from the factual correction, I am a proud Indian to begin with, there probably is some fact in it. Heck, without rice, curry, roti… what is the point of being an Indian to be honest? But why that extends to abuse, or to my kids, I am yet to understand. Anonymous account. yet another brave soul.

So far in life, and I am an unashamed fan of Twitter, warts and all, I have ignored all that. To read more, click here. 

Find out the latest diabetes vacancies available in the UK on our dedicated jobs page here.

A national diabetes charity has been shortlisted for a Quality in Care (QiC) award, it has been announced.

The Diabetes Research and Wellness Foundation (DRWF) has been shortlisted in the Empowering People with Diabetes category for an initiative it launched on the south coast, which has now been rolled out nationally. To read more, click here. 

A medical safety alert involving a greater risk of hypoglycaemia has been issued about a specific brand of insulin pen.

The Medicines and Healthcare Products Regulatory Agency has released information about the NovoPen Echo and NovoPen 5. Manufacturers Novo Nordisk say it is recalling 53 batches of the devices.

To read more, click here. 

Increasing the use of electronic health records could hold the key to determining whether metformin reduces the risk of cardiovascular disease among people with type 2 diabetes, according to new research.

Metformin is the most-prescribed oral medication to lower blood glucose worldwide. Yet previous systematic reviews have raised doubts about its effectiveness in reducing the risk of cardiovascular disease, the most costly complication of type 2 diabetes.

To read more, click here.

Young researchers who are dedicated to improving the lives of people with diabetes are being given the opportunity to showcase their innovation in a major award.

The International Diabetes Federation European Region (IDF Europe) is giving young people working within diabetes research the opportunity to promote their work across the continent and around the world with its annual Young Researcher award. To read more, click here.

One in three people with type 2 diabetes are sexually dissatisfied and almost two-thirds of these people report a need for help, new research has found.

Researchers now believe a simple screening checklist could be used to proactively identify sexually dissatisfied people in primary care. To read more, click here.

More than 600 children and young people have been treated for type 2 diabetes in the past year, a report has found.

The Local Government Association (LGA), which represents more than 370 councils in England and Wales, said local authorities must be given more funding urgently to tackle the “hugely disturbing” trend. To read more, click here.